Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.
Also called NCT04511000
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 250 participants
- Registry
-
NCT04511000
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT04511000. Randomized; no masking; primary purpose treatment. Start 2017-10-11 (actual); primary completion 2019-05-20 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Lipilou®(generic atorvastatin drug) 20 mg
- Intervention (Drug)
- Lipilou®(generic atorvastatin drug) 10 mg
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct04511000- Content hash
ce02a2bcfa355a5fb44b234cb57690ef8652495469f16e887247ce785c4cc6d0